Request Deal Involvement

A consortium of investors led a $273m Series C round in Generate Biomedicines.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

MIRAE ASSET FINANCIAL GROUP

bidder

MIRAE ASSET FINANCIAL GROUP

GENERATE BIOMEDICINES

target

GENERATE BIOMEDICINES

FLAGSHIP PIONEERING

bidder

FLAGSHIP PIONEERING

MORNINGSIDE VENTURE CAPITAL

bidder

MORNINGSIDE VENTURE CAPITAL

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

ARCH VENTURE PARTNERS

bidder

ARCH VENTURE PARTNERS

ABU DHABI INVESTMENT AUTHORITY (ADIA)

bidder

ABU DHABI INVESTMENT AUTHORITY (ADIA)

ALTITUDE LIFE SCIENCE VENTURES

bidder

ALTITUDE LIFE SCIENCE VENTURES

ALASKA PERMANENT FUND CORPORATION

bidder

ALASKA PERMANENT FUND CORPORATION

AMGEN VENTURES

bidder

AMGEN VENTURES

NVENTURES

bidder

NVENTURES

PICTET ALTERNATIVE ADVISORS

bidder

PICTET ALTERNATIVE ADVISORS

MARCH CAPITAL PARTNERS

bidder

MARCH CAPITAL PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - A consortium of investors led a $273m Series C round in Generate Biomedicines.